Literature DB >> 14742848

The role of overweight and obesity in calcium oxalate stone formation.

Roswitha Siener1, Sara Glatz, Claudia Nicolay, Albrecht Hesse.   

Abstract

OBJECTIVE: The aim of the study was to assess the influence of overweight and obesity on the risk of calcium oxalate stone formation. RESEARCH METHODS AND PROCEDURES: BMI, 24-hour urine, and serum parameters were evaluated in idiopathic calcium oxalate stone formers (363 men and 164 women) without medical or dietetic pretreatment.
RESULTS: Overweight and obesity were present in 59.2% of the men and in 43.9% of the women in the study population. Multiple linear regression analysis revealed a significant positive relationship between BMI and urinary uric acid, sodium, ammonium, and phosphate excretion and an inverse correlation between BMI and urinary pH in both men and women, whereas BMI was associated with urinary oxalate excretion only among women and with urinary calcium excretion only among men. Serum uric acid and creatinine concentrations were correlated with BMI in both genders. Because no association was established between BMI and urinary volume, magnesium, and citrate excretion, inhibitors of calcium oxalate stone formation, the risk of stone formation increased significantly with increasing BMI among both men and women with urolithiasis (p = 0.015). The risk of calcium oxalate stone formation, median number of stone episodes, and frequency of diet-related diseases were highest in overweight and obese men. DISCUSSION: Overweight and obesity are strongly associated with an elevated risk of stone formation in both genders due to an increased urinary excretion of promoters but not inhibitors of calcium oxalate stone formation. Overweight and obese men are more prone to stone formation than overweight women.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14742848     DOI: 10.1038/oby.2004.14

Source DB:  PubMed          Journal:  Obes Res        ISSN: 1071-7323


  81 in total

Review 1.  [Benign prostatic hyperplasia and urolithiasis].

Authors:  P Krombach; M S Michel
Journal:  Urologe A       Date:  2010-09       Impact factor: 0.639

2.  Effectiveness of retrograde intrarenal stone surgery in obese patients.

Authors:  O G Doluoglu; T Karakan; M Kabar; B C Ozgur; A M Hascicek; E Huri; B Resorlu
Journal:  Ir J Med Sci       Date:  2015-11-11       Impact factor: 1.568

3.  Risk of Nephrolithiasis in Patients With Sleep Apnea: A Population-Based Cohort Study.

Authors:  Sheng-Han Tsai; Marshall L Stoller; Benjamin A Sherer; Zi-Hao Chao; Tao-Hsin Tung
Journal:  J Clin Sleep Med       Date:  2018-05-15       Impact factor: 4.062

Review 4.  Recent advances in nutritional research on urolithiasis.

Authors:  Roswitha Siener; Albrecht Hesse
Journal:  World J Urol       Date:  2005-11-08       Impact factor: 4.226

Review 5.  Impact of dietary habits on stone incidence.

Authors:  Roswitha Siener
Journal:  Urol Res       Date:  2006-01-11

Review 6.  [Urinary calculi. Metabolism and diagnosis].

Authors:  R E Hautmann; M Straub
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

7.  [Modern general metaphylaxis of stone disease. New risks, new evidence, new recommendations].

Authors:  R Siener; A Hesse
Journal:  Urologe A       Date:  2006-11       Impact factor: 0.639

8.  Body fat content and distribution and urinary risk factors for nephrolithiasis.

Authors:  Federica Pigna; Khashayar Sakhaee; Beverley Adams-Huet; Naim M Maalouf
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 8.237

9.  Association Between Adiponectin and Insulin Resistance in Diabetic Urolithiasis.

Authors:  Dona Devasia; Kavitha Meiyappan; Palani Selvam Mohanraj; Dorairajan Lalgudi Narayanan; Gandhipuram Periyasamy Senthilkumar; Md Yasir
Journal:  Oman Med J       Date:  2017-03

10.  Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers.

Authors:  Armando Luis Negri; Francisco Rodolfo Spivacow; Elisa Elena Del Valle; Mariano Forrester; Gabriela Rosende; Irene Pinduli
Journal:  Urol Res       Date:  2008-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.